• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number WCD 4000
Device Problem Seal, defective (2301)
Patient Problem Burn(s) (1757)
Event Date 01/03/2015
Event Type  Injury  
Event Description
A zoll distributor reported that a (b)(6) male patient received an inappropriate treatment.On (b)(6) 2015, the patient received a treatment at 03:16:29 while sleeping.The rhythm at the time of the treatment was bradycardia with tall t waves and motion artifact.Multiple counting of the patient's rhythm contributed to the false detection.The patient did not press the response buttons prior to the treatment.The patient reported that the lifevest did not deploy gel and that the treatment had burned him.The patient went to the hospital for further evaluation.A distributor follow-up on (b)(6) 2014 indicated that the burn was improving.
 
Manufacturer Narrative
Device evaluation: device evaluation of electrode belt sn (b)(4) was completed.The reported problem (gel not deployed) was confirmed.Upon investigation the rear therapy electrodes properly deployed gel but the front therapy electrode did not deploy gel.The cause for the gel deployment failure was a leak in the seal surrounding the therapy electrode gas generator o-ring.The leak allowed the gas from the gas generator to escape through the leak instead of forcing gel out of the exit ports of the therapy electrode.The root cause for the o-ring leak could not be positively identified.The lifevest electrode belt therapy electrodes have a surface area well above (b)(4) requirements.The larger surface area helps to limit the risk of a patient receiving a burn if the electroconductive gel does not fully deploy.Additional inappropriate defibrillation narrative: inappropriate defibrillations are an anticipated risk associated with the use of the lifevest.Patients are instructed through alarms, voice messages, ifu, and training to press the response buttons to prevent an inappropriate defibrillation.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFEVEST WCD 4000 SYSTEM
Type of Device
WEARABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ZOLL MANUFACTURING CORPORATION
pittsburgh PA 15238 349
Manufacturer Contact
zachary nelson
121 gamma dr
pittsburgh, PA 15238-3495
4129683333
MDR Report Key4476100
MDR Text Key5401373
Report Number3008642652-2015-00443
Device Sequence Number1
Product Code MVK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Not Applicable
Type of Report Initial
Report Date 01/27/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/29/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberWCD 4000
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/13/2015
Is the Reporter a Health Professional? No
Date Manufacturer Received01/07/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/01/2014
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age65 YR
-
-